CN Patent

CN114805311A — 螺环茚

Assigned to Yasheng Pharmaceutical Group Hong Kong Co ltd · Expires 2022-07-29 · 4y expired

What this patent protects

本公开提供由式I表示的化合物，其中R 3 ,R 8c ,R 8d ,A,A 1 ,A 2 ,A 3 ,A 4 ,E,E 1 ,L,Q,Z,和如说明书中所定义，及其药学上可接受的盐和溶剂化物。式I化合物是KRAS抑制剂，因此可用于治疗癌症和其他疾病。。

USPTO Abstract

本公开提供由式I表示的化合物，其中R 3 ,R 8c ,R 8d ,A,A 1 ,A 2 ,A 3 ,A 4 ,E,E 1 ,L,Q,Z,和如说明书中所定义，及其药学上可接受的盐和溶剂化物。式I化合物是KRAS抑制剂，因此可用于治疗癌症和其他疾病。。

Drugs covered by this patent

Patent Metadata

Patent number: CN114805311A
Jurisdiction: CN
Classification: —
Expires: 2022-07-29
Drug substance claim: No
Drug product claim: No
Assignee: Yasheng Pharmaceutical Group Hong Kong Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.